Cryoablation Devices Market, By Device Type (Systems and Probes), By Application (Prostate Cancer, Renal Cancer, Cardiac Arrhythmia, Liver Cancer, and Breast Cancer), By End User (Hospitals, Ambulatory Surgical Centers, and Surgical Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Trends, Analysis and Forecast till 2034

Growing Incidence of Cancer

According to WHO, Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or almost one in six deaths.

Cryoablation is increasingly being used as a minimally invasive treatment option for various types of cancer, including liver, kidney, prostate, breast, and lung cancers. The rising incidence of cancer globally is a significant driver for the demand for cryoablation devices. A thin needle, called a cryoprobe, is placed directly into the cancerous growth under ultrasound or CT scan guidance. The cryoprobe circulates extremely cold gases like liquid nitrogen to freeze and kill cancer cells. The tissue is then allowed to thaw. Finally, another cycle of freezing is performed. The time required depends on the size, location, and type of tumor. And the kind of tumor.